FDA Adverse Event Injury Summary report: N

ENRHYTHM DR

MDR report key: 1990553 · Received February 15, 2011

Report

Report Number
6000144-2011-00751
Event Type
Injury
Date Received
February 15, 2011
Manufacturer
MEDTRONIC MED REL, INC.
Product Code
DXY
PMA / PMN Number
P980035/S38
Removal / Correction Number
ASKU
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. THE DEVICE IS PART OF THE ADVISORY FOR THIS MODEL. ANALYSIS OF THE DEVICE IS IN PROCESS; THE RESULTS WILL BE FORWARDED WHEN AVAILABLE.

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. THE DEVICE IS PART OF THE ADVISORY FOR THIS MODEL. EVALUATION SUMMARY: (B)(4): THE DEVICE WAS RETURNED AND THE ANALYSIS WAS INCOMPLETE BECAUSE THE DEVICE WAS DAMAGED DURING ANALYSIS.

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. THE DEVICE IS PART OF THE ADVISORY FOR THIS MODEL. EVALUATION SUMMARY: (B)(4): THE DEVICE WAS RETURNED, ANALYZED AND ANALYSIS OF THE DEVICE REVEALED HIGH BATTERY IMPEDANCE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE DEVICE BATTERY VOLTAGE DROPPED FROM 2.92 VOLTS TO 2.81 VOLTS IN FOUR DAYS. DISSATISFACTION WITH THE PRODUCT WAS ALSO REPORTED. THE DEVICE WAS EXPLANTED AND REPLACED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Description of Event or Problem · 1

ASKU

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENRHYTHM DR IMPLANTABLE PULSE GENERATOR DXY MEDTRONIC MED REL, INC. P1501DR ASKU

Patients

Seq Age Sex Outcome Treatment
1 66 YR Hospitalization| R (B)(4) COMPETITOR PACING LEAD| (B)(4) COMPETITOR PACING LEAD| (B)(4) COMPETITOR PACING LEAD| (B)(4) COMPETITOR PACING LEAD| (B)(4) COMPETITOR PACING LEAD| (B)(4) COMPETITOR PACING LEAD